학술논문
Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled By Functional Lipoprotein Nanoparticles and the B Cell Receptor Inhibitor Ibrutinib: A Therapeutic Strategy Dependent on Cell of Origin (COO)
Document Type
Abstract
Author
Source
In Blood 8 December 2017 130 Supplement 1:576-576
Subject
Language
ISSN
0006-4971